PD-1/PD-L1-checkpoint blockade therapy is generally thought to relieve tumor cell-mediated
suppression in the tumor microenvironment but PD-L1 is also expressed on non-tumor …

Structured abstract for full paper Background After recovery from COVID-19, most patients
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …

Why HIV-specific CD8 + T cells ultimately fail to clear or control HIV infection is not known.
We show here that HIV-specific CD8 + T cells exhibit increased sensitivity to CD95/Fas-…

We found upregulation of expression of the microRNA miR-155 in primary effector and effector
memory CD8 + T cells, but low miR-155 expression in naive and central memory cells. …

In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…

HIV-specific CD8 + T cells are prone to undergo apoptosis, and this may affect their ability to
control HIV infection. Because CD8-mediated immune responses play a key role in …

The failure of CD8+ T cells to respond to chronic infection has been termed “exhaustion” and
describes the condition in which CD8+ T cells exhibit reduced differentiation, proliferation, …

Interleukin-15 (IL-15) in vitro treatment of peripheral blood mononuclear cells (PBMC) from
human immunodeficiency virus (HIV)-infected individuals specifically enhances the function …

In this study, we examined the effect of in vivo treatment of acutely SIV-infected Mamu-A* 01+
rhesus macaques with IL-15. IL-15 treatment during acute infection increased viral set …

Given the key role CD8 + T cells play in controlling viral infection, strategies to enhance
these responses may have important clinical applications. We found that in vivo CD137 …